Group 1 - Jiangtian Chemical executed a block trade of 85,300 shares on November 6, with a transaction value of 2,000,300 yuan, accounting for 0.81% of the total trading volume for the day [1][2] - The transaction price was 23.45 yuan, which represents a discount of 14.54% compared to the market closing price of 27.44 yuan [1][2]

Core Points - Jiangtian Chemical (300927) announced on November 4 that as of October 31, 2025, the number of shareholders in its consolidated ordinary accounts and margin trading credit accounts will be 13,209 [1] Summary by Category - **Company Information** - Jiangtian Chemical's projected number of shareholders in consolidated accounts is 13,209 by October 31, 2025 [1]

Core Viewpoint - Jiangtian Chemical's stock has experienced fluctuations, with a year-to-date increase of 58.24%, but recent trends show a decline over the past 60 days [1][2]. Group 1: Stock Performance - On October 24, Jiangtian Chemical's stock price fell by 2.00% to 25.92 CNY per share, with a trading volume of 58.17 million CNY and a turnover rate of 1.57% [1]. - The company has seen a net outflow of 1.61 million CNY in principal funds, with large orders accounting for 18.40% of total purchases and 21.17% of total sales [1]. - The stock has been on the "Dragon and Tiger List" five times this year, with the most recent instance on May 19, where it recorded a net purchase of 41.23 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Jiangtian Chemical achieved a revenue of 1.11 billion CNY, representing a year-on-year growth of 112.58%, while the net profit attributable to shareholders decreased by 75.84% to 8.21 million CNY [2]. - The company's main business revenue composition includes functional polymer materials (60.89%), organic chemicals (37.03%), functional fine chemicals (1.53%), and others (0.55%) [1]. Group 3: Shareholder Information - As of October 20, Jiangtian Chemical had 13,200 shareholders, a decrease of 4.73% from the previous period, with an average of 10,650 circulating shares per shareholder, an increase of 4.97% [2]. Group 4: Dividend Information - Since its A-share listing, Jiangtian Chemical has distributed a total of 93.35 million CNY in dividends, with 53.41 million CNY distributed over the past three years [3].

Core Viewpoint - Jiangtian Chemical (300927) reported that as of October 20, 2025, the number of shareholders in its consolidated ordinary accounts and margin trading credit accounts is 13,228 [1] Summary by Category - **Company Information** - Jiangtian Chemical has a total of 13,228 shareholders in its combined ordinary and margin trading credit accounts as of the specified date [1]

Core Insights - Jiangtian Chemical (300927.SZ) reported significant revenue growth for the first three quarters of 2025, achieving 1.109 billion yuan, a year-on-year increase of 112.58% [1] - However, the net profit attributable to shareholders decreased by 75.84% to 8.2111 million yuan, and the net profit after excluding non-recurring gains and losses fell by 82.02% to 5.8108 million yuan [1] - The company generated a net cash flow from operating activities of 108 million yuan, marking a substantial increase of 485.32% [1] Financial Performance Summary - For Q3 2025, Jiangtian Chemical's revenue reached 357 million yuan, up 110.37% year-on-year [1] - The net profit attributable to shareholders for Q3 2025 was 7.9534 million yuan, a decline of 10.49% compared to the previous year [1] - The net profit after excluding non-recurring gains and losses for Q3 2025 was 7.9355 million yuan, reflecting a growth of 2.79% [1] Previous Year Comparison - In 2024, Jiangtian Chemical reported revenue of 688 million yuan, a decrease of 2.92% year-on-year [1] - The net profit attributable to shareholders in 2024 was 298 million yuan, an increase of 334.35% [1] - The net profit after excluding non-recurring gains and losses for 2024 was 40.0871 million yuan, down 39.48% [1] - The net cash flow from operating activities in 2024 was 16.3287 million yuan, a decline of 81.27% [1] Company Background - Jiangtian Chemical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on January 7, 2021, with an initial public offering of 20.05 million shares at a price of 13.39 yuan per share [2] - The total funds raised from the IPO amounted to approximately 268.47 million yuan, with a net amount of about 228.48 million yuan after deducting issuance costs [2] - The company planned to use the raised funds for various projects, including the production of specific chemical products and the establishment of a green intelligent factory [2]

Core Viewpoint - Jiangtian Chemical announced the election of its fifth board of directors, consisting of 9 members, with 6 non-independent directors and 3 independent directors [2] Group 1: Board Composition - The fifth board of directors will include 6 non-independent directors and 3 independent directors [2] - One of the non-independent directors is an employee representative elected by the employee representative assembly, which does not require shareholder meeting approval [2] Group 2: Director Nominations - The board's nomination committee has approved the nomination of 8 candidates for the fifth board, including 5 non-independent directors and 3 independent directors [2] - The nominated independent director, Yu Dong, is a professional accountant [2]

Core Insights - Jiangtian Chemical reported a significant increase in revenue for Q3 2025, achieving 356,582,306.91 yuan, which represents a year-on-year growth of 110.37% [2] - However, the net profit attributable to shareholders decreased to 7,953,397.96 yuan, reflecting a year-on-year decline of 10.49% [2] Financial Performance - Revenue for Q3 2025: 356.58 million yuan, up 110.37% year-on-year [2] - Net profit for Q3 2025: 7.95 million yuan, down 10.49% year-on-year [2]

Core Viewpoint - Jiangtian Chemical (300927.SZ) reported significant revenue growth in the third quarter, but net profit experienced a substantial decline [1] Financial Performance - The company achieved a revenue of 1.109 billion yuan in the first three quarters, representing a year-on-year increase of 112.58% [1] - The net profit attributable to shareholders was 8.21 million yuan, reflecting a year-on-year decrease of 75.84% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 5.81 million yuan, down 82.02% year-on-year [1]

Group 1 - The core point of the article highlights Jiangtian Chemical's significant revenue growth in Q3 2025, with a year-on-year increase of 112.58%, reaching approximately 1.109 billion yuan [1] - The net profit attributable to shareholders decreased by 75.84%, amounting to around 8.21 million yuan [1] - Basic earnings per share also saw a decline of 75.83%, reported at 0.0569 yuan [1] Group 2 - As of the report, Jiangtian Chemical's market capitalization stands at 3.8 billion yuan [1]

证券代码：300927 证券简称：江天化学 公告编号：2025-046 声明人吴建新作为南通江天化学股份有限公司第5届董事会 独立董事候选人，已充分了解并同意由提名人南通江天化学股份有 限公司董事会提名为南通江天化学股份有限公司(以下简称该公司) 第5届董事会独立董事候选人。现公开声明和保证，本人与该 公司之间不存在任何影响本人独立性的关系，且符合相关法 律、行政法规、部门规章、规范性文件和深圳证券交易所业 务规则对独立董事候选人任职资格及独立性的要求，具体声 明并承诺如下事项： 一、本人已经通过南通江天化学股份有限公司第4届董事会提 名委员会或者独立董事专门会议资格审查，提名人与本人不 存在利害关系或者其他可能影响独立履职情形的密切关系。 ☑ 是 □否 如否，请详细说明：______________________________ 二 、本人不存在《中华人民共和国公司法》第一百四十 六条等规定不得担任公司董事的情形。 ☑ 是 否 如否，请详细说明：______________________________ 三 、本人符合中国证监会《上市公司独立董事管理办法》 和深圳证券交易所业务规则规定的独立董事任职资格 ...